Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Early-stage HER2-positive breast cancer Age: Adult Condition: Extended adjuvant treatment following Trastuzumab based therapy |
Dose: Tablet – 240 mg (6 tablets) Frequency: once daily Duration: up to 1 year Note: Given by mouth with food continuously until disease recurrence. |
|
Indication: Advanced or metastatic HER2-positive breast cancer Age: Adult Condition: Received two or more prior anti-HER2 based regimens; in combination with Capecitabine |
Dose: Tablet – 240 mg (6 tablets) Frequency: once daily Duration: until disease progression or unacceptable toxicities Note: Given by mouth with food on Days 1–21 of a 21-day cycle. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: No approved pediatric dosage available Note: Not recommended |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Dose: Note: No clinical significant effect on pharmacokinetics; No dose adjustment required |
Administration
- Take with food
- Take at same time daily
Side Effect
- Diarrhea, all grades (95%)
- Nausea (43%)
- Diarrhea, grade 3 (40%)
- Abdominal pain (36%)
- Fatigue (27%)
- Vomiting (26%)
- Rash (18%)
- Stomatitis (14%)
- Decreased appetite (12%)
- Muscle spasms (11%)
- Dyspepsia (10%)
- Increased ALT (9%)
- Nail disorder (8%)
- Increased AST (7%)
- Dry skin (6%)
- Abdominal distension (5%)
- Epistaxis (5%)
- Urinary Tract Infection (UTI) (5%)
- Weight decreased (5%)
- Dehydration (4%)
- Dry mouth (3%)
- Skin fissures (2%)
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Rifampin, carbamazepine
|
Decrease neratinib serum levels
|
|
Ketoconazole, ritonavir, clarithromycin, grapefruit juice
|
May increase neratinib serum levels
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
No specific contraindications listed
|
Monitor for general drug reactions
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store Neratinib at room temperature between 20° to 25°C. Keep Neratinib and all medicines out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.